Search company, investor...
Vivostat company logo

Vivostat

vivostat.com

Founded Year

2000

Stage

Unattributed VC - II | Alive

Total Raised

$13.3M

Last Raised

$4M | 14 yrs ago

About Vivostat

Vivostat, produces a simple and fully automated way of preparing fibrin sealant, onsite and from the patient's own blood.

Headquarters Location

Borupvang 2

Alleroed, 345,

Denmark

+45 2711 1962

Missing: Vivostat's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Vivostat's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Vivostat Patents

Vivostat has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/11/2011

9/22/2015

Blood tests, IBM mainframe technology, Immunologic tests, IBM microprocessors, IBM minicomputers

Grant

Application Date

11/11/2011

Grant Date

9/22/2015

Title

Related Topics

Blood tests, IBM mainframe technology, Immunologic tests, IBM microprocessors, IBM minicomputers

Status

Grant

Latest Vivostat News

Surgical Glue Market will value USD 4.26 billion by 2030 : GreyViews

Jan 23, 2023

Major Players CSL Limited, Sanofi, CryoLife Inc., Baxter International Inc., Johnson & Johnson, Sealants Ltd., Cohera Medical, Inc., B. Braun Melsungen AG, Vivostat, Ocular Therapeutics Inc., among others Segmentation Analysis Synthetic & semi-synthetic adhesives & sealants are expected to be the fastest-growing segment in 2022. The product type segments include natural adhesives & sealants and synthetic & semi-synthetic adhesives & sealants. The synthetic & semi-synthetic adhesives & sealants segment is expected to witness the highest growth rate during the forecast period. As a result of the increased number of children being circumcised, the demand for synthetic and semi-synthetic adhesives and sealants is expected to grow rapidly during the forecasted period. As pediatricians begin to prescribe cyanoacrylate adhesives for treating wounds and cuts in children, the number of circumcisions is expected to increase as well. Food is expected to be the fastest-growing segment in 2022. The application segments include neurosurgery, burn bleeding, cardiovascular surgery, pulmonary surgery, liver and spleen laceration, plastic surgery, wound healing, and others. The cardiovascular surgery segment is expected to witness the highest growth rate during the forecast period. It is expected that the cardiovascular surgery segment will grow significantly over the forecast period, as the number of patients suffering from CVDs is increasing, resulting in an increase in cardiovascular surgeries. In addition to reducing blood loss post-surgery, surgical hemostats can also prevent tissue damage. Regional Analysis            The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the surgical glue market include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia. The North American region witnessed a major share. There was a dominant market for surgical glue in North America during the forecast period, and North America is expected to maintain its dominance during the forecast period. Several factors contribute to the growth of the medical adhesive market, including an increase in R&D investments in medical adhesives and their applications in different surgeries. Country Analysis Germany Germany's surgical glue market size was valued at USD 0.15 billion in 2021 and is expected to reach USD 2.26 billion by 2029, at a CAGR of 7.3% from 2023 to 2030. The surgical glue market in the country is expected to be driven by product line extension and new product innovations. The increasing healthcare expenditures per capita and cost containment measures to reduce the burden of healthcare in the country are also expected to boost market growth. China China’s surgical glue market size was valued at USD 0.19 billion in 2021 and is expected to reach USD 2.33 billion by 2029, at a CAGR of 7.5% from 2023 to 2030. As a result of the growing population of the country, the country has adopted and advanced technology; the number of people suffering from obesity, cancer, and other deadly diseases has increased. Traumatic injuries are on the rise, disposable medical devices are being used more frequently, and advanced medical equipment and devices are becoming more commonplace. India India's surgical glue market size was valued at USD 0.14 billion in 2021 and is expected to reach USD 2.24 billion by 2029, at a CAGR of 7.4% from 2023 to 2030. In India, as a result of high disposable income, advancements in healthcare infrastructure increased awareness and an increase in traumatic injuries, the surgical glue market is expected to grow over the forecast period. Covid-19 Impact Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries. Furthermore, the growth of this market is mainly driven owing to the rising demand from the automobile and agriculture sector, propelling the growth of the market across the countries. Buy Now Full Report @ https://greyviews.com/checkout/434/single_user_license Contact Us

Vivostat Frequently Asked Questions (FAQ)

  • When was Vivostat founded?

    Vivostat was founded in 2000.

  • Where is Vivostat's headquarters?

    Vivostat's headquarters is located at Borupvang 2, Alleroed.

  • What is Vivostat's latest funding round?

    Vivostat's latest funding round is Unattributed VC - II.

  • How much did Vivostat raise?

    Vivostat raised a total of $13.3M.

  • Who are the investors of Vivostat?

    Investors of Vivostat include Vækstfonden, Seventure Partners, Dansk Innovationsinvestering, Vecata, Dansk Kapital and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.